ESC Premium Access

Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study

Congress Session

About the speaker

Doctor Laila Staerk

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)
0 follower

3 more presentations in this session

PDK1 determines collagen-dependent platelet activation and is critical to development of arterial thrombosis and ischemic stroke in vivo

Speaker: Doctor O. Borst (Tuebingen, DE)


A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial

Speaker: Doctor C. Fanola (Boston, US)


Clinical impact and course of major bleeding events in patients with venous thromboembolism, treated with factor Xa inhibitors or vitamin K antagonists: an individual patient data analysis

Speaker: Ms M. Brekelmans (Amsterdam, NL)


Access the full session

Young Investigators Awards Session Thrombosis

Speakers: Doctor L. Staerk, Doctor O. Borst, Doctor C. Fanola, Ms M. Brekelmans

About the event



27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk